Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies

Abstract

PDXs for EOC with histopathological and genetic stability can be efficiently developed by subrenal capsule implantation and have the potential to provide a promising platform for future translational research and precision medicine for EOC.